Skip to Main Content

Paper Details

SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
Neuro Oncol
14
2022
). 1q, 1q, Children, Ependymoma, Grade, Grade 3 tumours, H3K27me3, Participants, ReLA, STR, Tenascin-C, VEC, children, cyclophosphamide, ependymoma, etoposide, hTERT, non-metastatic intracranial ependymoma, pAKT, participants, vincristine
Author NameAffiliation
Piergiorgio ModenaASST Lariana General Hospital
Tim JaspanNottingham University Hospitals NHS Trust
Kristian W PajtlerHopp Children's Cancer Center Heidelberg (KiTZ)
Kristian W PajtlerUniversity Hospital Heidelberg
Kristian W PajtlerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Kristian W PajtlerHopp Children's Cancer Center Heidelberg (KiTZ)
Kristian W PajtlerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Kristian W PajtlerUniversity Hospital Heidelberg
Thomas S JacquesUCL GOS Institute of Child Health
Thomas S JacquesGreat Ormond Street Hospital for Children NHS Foundation Trust
David W EllisonSt. Jude Children's Research Hospital
Eric BouffetThe Hospital for Sick Children
  • 1 - 12

Datasets

Release 1.2